Collaborative study led by Dr. Katerina Akassoglou and UCLA Labs, including Dr. Mehdi Bouhaddou's lab, reports Fibrin drives Thromboinflammation and Neuropathology in COVID-19

A collaborative study led by Dr. Katerina Akassoglou and UCLA Labs, including Dr. Mehdi Bouhaddou's lab, reports that fibrin drives thromboinflammation and neuropathology in SARS-CoV-2 infection. Fibrin-targeting immunotherapy may represent a therapeutic intervention for patients with acute COVID-19 and long COVID.

A shout out to postdoctoral Prashant Kaushal and PhD student Sara Makanani, who are both in Dr. Mehdi Bouhaddou’s lab.

Read more and download the full article at Nature.com.